Pan Solid Tumor Identification of NRG1 Fusions Utilizing RNA Sequencing Identifies Diverse Fusion Partners and Highlights a Lack of Co occurring Oncogenic Driver Alterations. | Labcorp Oncology Skip to main contentScroll Back to Top
Our global life sciences company brings diagnostic testing & drug development together.
Pan Solid Tumor Identification of NRG1 Fusions Utilizing RNA Sequencing Identifies Diverse Fusion Partners and Highlights a Lack of Co occurring Oncogenic Driver Alterations.
Poster
Pan Solid Tumor Identification of NRG1 Fusions Utilizing RNA Sequencing Identifies Diverse Fusion Partners and Highlights a Lack of Co occurring Oncogenic Driver Alterations.